Skip to main content

Table 1 Subject characteristics

From: Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics

 

All (n = 32)

Single responders (n = 18)

Dual responders (n = 14)

Sex (F/M)

16/16

9/9

7/7

Age (y)

27 (24–37)

27 (26–42)*

24 (22–30)*

BMI

24 (22–26)

23 (22–26)

24 (23–26)

Regular ICS use (n)

15

6

9

FEV1 Baseline (% predicted)

96 (90–104)

95 (88–103)

95 (92–105)

Early drop in FEV1 (%)

23 (21–25)

22 (21–25)

23 (21–25)

Max. drop in FEV1 after 4–8 h (%)

10 (7–17)

7 (5–9)

20 (15–24)

Allergen used in challenge (n) (Cat/Horse/HDM/ Birch/Grass)

17/6/2/4/3

10/4/1/2/1

7/2/1/2/2

  1. Data presented as median (IQR). BMI = body mass index, FEV1 = forced expiratory volume in 1 s, ICS = inhaled glucocorticosteroid (maximal dose of 400 μg Budesonide/day) 
  2. Statistical differences between single and dual responders were analysed using non-parametric Mann–Whitney, *denotes p < 0.05